Standout Papers

Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges 2023 2026 2024149
  1. Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges (2023)
    Chunyan Duan, Mingjia Yu et al. Biomedicine & Pharmacotherapy

Immediate Impact

59 standout
Sub-graph 1 of 22

Citing Papers

Institutional investor ESG activism and corporate green innovation against climate change: Exploring differences between digital and non-digital firms
2024 Standout
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
2 intermediate papers

Works of Boyi Li being referenced

Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer
2021
Relational and institutional embeddedness of Web‐enabled entrepreneurial networks: case studies of netrepreneurs in China
2013

Author Peers

Author Last Decade Papers Cites
Boyi Li 46 18 20 80 53 6 229
Yoon Khei Ho 13 7 4 131 19 16 293
Thomas Snavely 27 40 4 81 28 5 204
Robert Mittman 10 19 4 33 16 4 188
Pınar Özkan 10 6 3 43 10 14 247
Yi-Lin Lee 13 2 25 19 15 215
Katrin Naumann 23 2 58 5 6 289
Jesús Sánchez 20 1 8 111 5 10 248
Shuhuan Wu 14 9 54 11 8 159
Caterina Trevisan 6 8 3 185 5 5 251
Bin Yang 5 3 7 47 9 7 136

All Works

Loading papers...

Rankless by CCL
2026